Olithro Eye Ointment contains Azithromycin 1% w/w, a macrolide antibiotic effective against a broad spectrum of gram-positive and gram-negative bacteria. It is indicated for the treatment of bacterial conjunctivitis and other superficial ocular infections caused by susceptible organisms. Azithromycin acts by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit, thereby preventing bacterial growth and replication. Olithro Eye Ointment is formulated to provide sustained drug release, enhancing ocular tissue penetration and maintaining therapeutic concentrations for prolonged periods. This formulation is particularly useful in treating infections caused by pathogens such as Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. The ointment is applied topically to the affected eye(s) as prescribed, typically one or two times daily, ensuring ease of use and improved patient compliance. Adverse effects are generally mild and may include transient ocular irritation, burning sensation, or blurred vision upon application. Olithro Eye Ointment should be used with caution in patients with known hypersensitivity to macrolides. It is contraindicated in viral, fungal, or mycobacterial eye infections. Proper hygiene and adherence to dosing instructions are essential to prevent contamination and ensure optimal therapeutic outcomes.